Zhao, H.; Xu, Q.; Gao, R.; Yin, B.; Sun, G.; Xue, K.; Yang, Y.; Li, E.; Zhu, L.; Feng, F.;
et al. Clinical Feasibility of 5.0 T MRI/MRCP in Characterizing Pancreatic Cystic Lesions: Comparison with 3.0 T and MDCT. Diagnostics 2024, 14, 2457.
https://doi.org/10.3390/diagnostics14212457
AMA Style
Zhao H, Xu Q, Gao R, Yin B, Sun G, Xue K, Yang Y, Li E, Zhu L, Feng F,
et al. Clinical Feasibility of 5.0 T MRI/MRCP in Characterizing Pancreatic Cystic Lesions: Comparison with 3.0 T and MDCT. Diagnostics. 2024; 14(21):2457.
https://doi.org/10.3390/diagnostics14212457
Chicago/Turabian Style
Zhao, Huijia, Qiang Xu, Ruichen Gao, Bohui Yin, Gan Sun, Ke Xue, Yuxin Yang, Enhui Li, Liang Zhu, Feng Feng,
and et al. 2024. "Clinical Feasibility of 5.0 T MRI/MRCP in Characterizing Pancreatic Cystic Lesions: Comparison with 3.0 T and MDCT" Diagnostics 14, no. 21: 2457.
https://doi.org/10.3390/diagnostics14212457
APA Style
Zhao, H., Xu, Q., Gao, R., Yin, B., Sun, G., Xue, K., Yang, Y., Li, E., Zhu, L., Feng, F., & Wu, W.
(2024). Clinical Feasibility of 5.0 T MRI/MRCP in Characterizing Pancreatic Cystic Lesions: Comparison with 3.0 T and MDCT. Diagnostics, 14(21), 2457.
https://doi.org/10.3390/diagnostics14212457